On one hand, recent reports suggest that in non-small cell lung cancer (NSCLC), high A2AR expression in the TME independently predicted better patient overall survival (OS), while high CD73 levels were associated with poor OS (69). This evidence concerns the gene NT5E and non-small cell lung carcinoma.